Trials & Tribulations MRI-guided radiotherapy for prostate cancer: Lessons from the MIRAGE trial February 03, 2023Vol.49 No.05By Amar U. Kishan
FreeTrials & Tribulations Ignore at your own risk: FDA draft guidance puts flashing lights around “dose optimization” January 27, 2023Vol.49 No.04By Mark J. Ratain and Garth W. Strohbehn
Trials & Tribulations Pancreatic cancer survival edges up—as screening strategies emerge January 20, 2023Vol.49 No.03By Rosario Ligresti
Trials & Tribulations All colorectal cancer patients require germline testing at diagnosis and somatic testing at advanced disease diagnosis July 15, 2022Vol.48 No.28By Wenora Johnson, Danielle Ripley-Burgess, Heather Hampel, Folasade (Fola) P. May, Anjee Davis and Richard M. Goldberg
Trials & Tribulations Burnout from the elusive quest for quality July 15, 2022Vol.48 No.28By Banu E. Symington
Trials & Tribulations Transforming the future of radiation oncology:Three ways collaboration accelerates FLASH radiation therapy research June 24, 2022Vol.48 No.25By Karen J. Kirkby
Trials & Tribulations ANCHOR trial shows that treatment of anal high-grade squamous intraepithelial lesions prevents anal cancer in people with HIV June 17, 2022Vol.48 No.24By Joel M. Palefsky and Robert Yarchoan
Trials & Tribulations Cancer is complex and dynamic—ergo, dose optimization calls for mathematical modeling May 13, 2022Vol.48 No.19By Alexander Anderson, Robert Gillies and Robert Gatenby
FreeTrials & Tribulations Let’s close this safety loophole in cancer care April 15, 2022Vol.48 No.15By Daniel E. Fass, Stuart P. Feldman and Mary Farrell Ajango
Trials & Tribulations Here’s how we can make clinical trials more inclusive February 11, 2022Vol.48 No.06By Jenny Sherak
